Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103761225 | 10376122 | 5 | F | 20160822 | 20140811 | 20160823 | EXP | MW-BRISTOL-MYERS SQUIBB COMPANY-21278197 | BRISTOL MYERS SQUIBB | 0.00 | M | Y | 1.70000 | KG | 20160823 | CN | US | MW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103761225 | 10376122 | 1 | PS | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | 1 | Transplacental | 300 MG, QD | U | 21567 | 300 | MG | QD | ||||||
| 103761225 | 10376122 | 2 | SS | EFAVIRENZ | EFAVIRENZ | 1 | Transplacental | UNK | U | 0 | CAPSULE, HARD | ||||||||
| 103761225 | 10376122 | 3 | C | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Transplacental | 1 DF, UNK | U | 0 | 1 | DF | |||||||
| 103761225 | 10376122 | 4 | C | KALETRA | LOPINAVIRRITONAVIR | 1 | Transplacental | UNK | U | 0 | |||||||||
| 103761225 | 10376122 | 5 | C | COMBIVIR | LAMIVUDINEIDOVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 103761225 | 10376122 | 6 | C | NORVIR | RITONAVIR | 1 | Transplacental | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103761225 | 10376122 | 1 | Product used for unknown indication |
| 103761225 | 10376122 | 2 | Product used for unknown indication |
| 103761225 | 10376122 | 3 | Product used for unknown indication |
| 103761225 | 10376122 | 4 | Product used for unknown indication |
| 103761225 | 10376122 | 5 | Product used for unknown indication |
| 103761225 | 10376122 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103761225 | 10376122 | CA |
| 103761225 | 10376122 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103761225 | 10376122 | Accessory auricle | |
| 103761225 | 10376122 | Foetal exposure during pregnancy | |
| 103761225 | 10376122 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103761225 | 10376122 | 1 | 20120426 | 20140410 | 0 | |
| 103761225 | 10376122 | 2 | 20110608 | 0 | ||
| 103761225 | 10376122 | 3 | 20120426 | 20140515 | 0 | |
| 103761225 | 10376122 | 4 | 20140410 | 20140515 | 0 | |
| 103761225 | 10376122 | 5 | 20110608 | 0 | ||
| 103761225 | 10376122 | 6 | 20120426 | 20140410 | 0 |